logo
Employers are scrambling to cut costs and health care benefits are on the chopping block

Employers are scrambling to cut costs and health care benefits are on the chopping block

Yahoo16-07-2025
Good morning!
Health care costs have been rising for years, and finding a way to shoulder that burden and keep benefit prices low has been top of mind for employers. But companies are reaching their limit, and becoming more willing to push costs onto their employees, according to a new report.
Around 51% of companies say they're likely or very likely to make design changes to their plans in 2026 that will place a larger burden on employees, according to a new study from HR consulting firm Mercer. That's up from 45% last year. Their methods are expected to include raising deductibles and out-of-pocket maximums for employees.
Health care costs for workers are already up. The average costs of those benefits are expected to grow by 5.8% this year, up from 4.5% last year, according to the report. That's after accounting for any cost-reduction strategies, without which employers estimate that prices could actually rise around 8% this year.
This increase in health care costs is largely due to an increase in prescription drug prices. Well over half of employers (61%) are now actively looking for some type of alternative to typical pharmacy benefit contracts.
The increased popularity of GLP-1 weight-loss medications, which can cost around $1,000 per month per patient, is also contributing to higher benefit costs. Most organizations (77%) ranked managing the costs of these drugs as their highest priority when it comes to pharmacy benefits. But while the employers said they were more likely to add the coverage for 2025 than drop it, it's unclear if that will be the case next year, according to the report.
'While the trend over the past couple of years has been to add coverage for GLP-1s approved for weight-loss, some employers facing large cost increases in 2026 may feel this coverage is out of reach,' says Alysha Fluno, pharmacy innovation leader at Mercer. 'Employers are weighing the immediate costs of covering these drugs against the potential for generating savings down the road once their workforce's health improves.'
In the future, employers may require more documentation from employees who use GLP-1s, increase the eligibility requirements, or limit the number of providers and pharmacies for the medication, according to the report.
'While short-term cost containment actions might be needed to address current budget realities, we also see some employers using longer-term strategies, such as offering narrow network plans, that emphasize high-quality, high-value care,' says Ed Lehman, Mercer's U.S. health and benefits leader. 'These strategies may improve health outcomes or make health care more affordable for employees.'
Brit Morsebrit.morse@fortune.com
This story was originally featured on Fortune.com
Solve the daily Crossword
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

The FDA must crack down on dangerous knockoff weight-loss drugs
The FDA must crack down on dangerous knockoff weight-loss drugs

The Hill

time10 hours ago

  • The Hill

The FDA must crack down on dangerous knockoff weight-loss drugs

For the first time, there is real hope in the fight against obesity. New data from the Centers for Disease Control and Prevention's National Center for Health Statistics shows that adult obesity rates in the U.S. may finally be flatlining after annual increases since at least 2011. Obesity has long been understood to be the second leading cause of preventable death in America. Neither negative cultural attitudes about weight nor government messaging campaigns about diets have helped curb it. Yet like most insurmountable problems, we are innovating our way out of it. Experts believe a significant part of recent progress is due to powerful new medications such as Ozempic and Mounjaro, known as GLP-1 drugs. But just as these drugs are changing lives, a dangerous shadow market is growing alongside them. Compounded versions, which are copies of the original drugs made in smaller pharmacies, are flooding websites, med spas and clinics. These versions are often cheaper and easier to get than the real thing. They are also frequently untested, poorly regulated and, in many cases, illegal. The FDA has received more than 500 reports of serious side effects tied to compounded semaglutide and tirzepatide, the active ingredients in Ozempic and Mounjaro. Some patients have landed in the hospital after taking the wrong dose. That is not surprising when you consider that many of these vials come without proper labels or instructions. In 2023 alone, poison control centers received nearly 3,000 semaglutide-related calls, a huge jump from previous years. Many of those cases involved compounded or mislabeled versions of the medication. There are also serious concerns about what is actually in these products. The FDA has warned that some pharmacies are using different chemical forms of semaglutide, called salt forms, that are not approved for use and may not be safe. In April 2025, the agency seized counterfeit Ozempic from the U.S. supply chain after discovering that some vials contained the wrong ingredients or were contaminated with dangerous bacteria. These are not technical violations. They are real risks to people's health. During earlier shortages, compounding was allowed under special circumstances. But those shortages have ended, and the FDA has ordered most pharmacies to stop making these versions. Despite that, many continue to operate in legal gray zones or offer these drugs online. The harm does not stop with safety concerns. This trend also threatens future breakthroughs in obesity care. Companies like Novo Nordisk and Eli Lilly spent years and billions of dollars to develop these treatments. Now, they and others are working on new and even more effective drugs. When unapproved copies flood the market, it becomes harder to fund innovation. If investors cannot count on fair returns, the next generation of such medications may not make it out of the lab. Perhaps the biggest risk is to public trust. When someone has a bad experience with a fake or contaminated version, they may begin to doubt all weight loss innovations. That fear can ripple through the health system, making insurers and doctors more hesitant to support treatments that are helping with the genuine public health emergency of obesity. None of this means that compounding should disappear. It has a place when patients have specific medical needs that cannot be met by the approved versions, such as allergies or special dosing requirements. But what is happening now is not about rare exceptions. The FDA should continue cracking down on compounders that use unapproved ingredients or sell mislabeled products disguised as 'research chemicals.' At the same time, insurers and lawmakers need to make the real thing more affordable by removing middlemen such as pharmacy benefit managers. No one should have to choose between risking their health and going broke. We are finally making progress against a disease that affects nearly half the country and has stumped policymakers and advocates for decades. But progress is fragile. Unregulated versions of GLP-1s cannot be allowed to dominate the market. We risk undoing the progress reported by the CDC in the fight against obesity, and if we get this right, the trend could be reversed. That means longer lives for more people, lived in dignity and to the fullest.

Nature's First Aid: How Herbs Speed Up Fracture Healing and Soothe Pain
Nature's First Aid: How Herbs Speed Up Fracture Healing and Soothe Pain

Epoch Times

timea day ago

  • Epoch Times

Nature's First Aid: How Herbs Speed Up Fracture Healing and Soothe Pain

While crossing the street in laced-up heels, Erica Kuo—a certified clinical aromatherapist and herbal aromatherapy educator—tripped when one of her laces came loose. Acting quickly, she reached into her bag and applied arnica cream, an herbal salve she always carries for emergencies. A hospital visit later confirmed a fractured toe, and a fixation device was used to stabilize it. During the three-month recovery period, Kuo relied on herbal teas, botanical oils, and creams, which she applied directly to the injury, to relieve swelling and pain while supporting her body's natural healing process. Natural remedies, Kuo noted in an episode on Health 1+1, can effectively aid recovery and provide relief, alleviating the need for conventional painkillers.

Gym bros are taking these 'natural' injections to build muscle
Gym bros are taking these 'natural' injections to build muscle

Business Insider

time2 days ago

  • Business Insider

Gym bros are taking these 'natural' injections to build muscle

Hello! I'm Mia de Graaf. I run health coverage at Business Insider, and I'm stepping in for Joi-Marie this week while she's on vacation. Physically, I will be at home in New York City this summer. Mentally? Not so. This weekend, I am attempting to transport myself from my kitchen to Florence, Italy, with a zesty homemade agnolotti. Garlic, chiles, dill, and lime? Sign me up. On the agenda: Colonoscopies aren't fun. These new at-home colon cancer screenings offer a shortcut. Eight successful women in different industries told BI how they start their days. Here's one trick to escape huge crowds in Japan during peak season. Moms love this Yeti tote bag — and it's catching Wall Street's attention. But first: Let's check in on gym bros. If this was forwarded to you, sign up here. Download Business Insider's app here. This week's dispatch Hot peptide summer Earlier this week, I fell down a truly epic TikTok rabbit hole. It started with one video: a guy with cartoonish muscles bulging out of a tank top, sitting at his kitchen counter with six vials and a syringe. "It's time for me to get back in shape," he said. "So this is my new peptide stack." A whole hour later, I was deep in the bro wellness multiverse, where peptides rule. Peptides are short-chain amino acids, the building blocks of protein. In theory, you can use different peptides to stimulate different hormones for all kinds of results. You may have heard of peptide serums promising to boost collagen in your cheeks, or the weight-loss drug Ozempic, a peptide that suppresses hunger. Then, there are peptide shots that you can inject for muscle growth. The chiseled men on my phone screen told me that the idea is to "stack" various peptide shots because each one has slightly different effects. One may stimulate lean muscle, or melt fat for muscle definition, or heal your gym injuries, or slow aging. They rattled off laundry lists of technical names: BPC-157, CJC-1295, ipamorelin, follastatin 344, IGF-1… it goes on. There is a catch. As my colleague Hilary Brueck reports, the science behind muscle-building peptides is scant. Still, the trend is booming. Doctors say they are increasingly fielding questions from patients about which peptides they should use to retain muscle mass. The Vitamin Shoppe has seen a huge uptick in searches for peptides. Why? We're in our "natural gains" era. These days, quiet glow-ups are the hottest thing in cosmetic surgery. Similarly, drugs like steroids, which replace growth hormones, are seen as old-fashioned and toxic. Peptides stimulate your body's natural processes, so they're seen as more natural. This summer, beach bods are in — with a little help from a fridge full of syringes. Check your risk (at home) Colon cancer is the second-deadliest cancer in the US, in large part because people aren't getting their colon checked often enough. While colonoscopies are the most reliable tool, a new suite of at-home tests is rapidly expanding. One recently approved screening tool checks your blood for signs that something is awry. Another highly anticipated test, which isn't out yet, may require nothing more than your breath. Four colonoscopy alternatives. She wakes up like this There's no one-size-fits-all approach to optimizing your morning routine. However, there are a lot of options to try out and many recipes for success. BI spoke to eight successful women across different industries, from professional dancers to bankers and CEOs. Most said they wake up around 6 a.m., but their routines diverge from there. Some hit the gym, while others do affirmations. Also read: Seven men told us how they start their days. Fancy alarm clocks and morning runs are key to their success. Sakura season, without the crowds BI's Anneta Konstantinides visited Japan for its famed cherry blossom season in March, right as the country was experiencing record tourism. While the most popular attractions in Tokyo and Kyoto felt crowded, Konstantinides quickly figured out an easy, affordable, and crowd-free way to enjoy the sights in peak bloom. The secret was in Japan's gardens. The holy grail mom bag The Yeti Camino 35 Caryall Tote Bag has a chokehold on moms on TikTok. They tout it as the sleekest, most durable bag for carrying an array of items while also ferrying their children from place to place. It's even got Wall Street's attention. In a recent note, Jefferies analysts said the Camino 35's virality is boosting confidence in Yeti Holdings' stock. Check it out. What we're watching this weekend "Happy Gilmore 2": Nearly three decades after Adam Sandler's comedy about an unlikely golf hero hit theaters, the comedian's star-studded sequel is coming to Netflix. "The Phoenician Scheme": Wes Anderson's latest film, a surprisingly comedic crime caper starring Benicio del Toro, makes its streaming debut on Peacock. "Hitmakers": Netflix's new reality docuseries about the glamorously cutthroat world of professional songwriting is an entertaining peek behind the curtain at how some of your favorite pop songs get made. What to shop New Yorker must-haves: Discover editor Gabrielle Chase's guide to NYC essentials — packed with smart recommendations on what to pack, where to shop, and how to blend in like a local. One ring to track it all: We put the Oura Ring 4 to the test. It packs powerful health tracking into a sleek, screen-free design. It's discreet, durable, and lasts a week on a charge, but its high price keeps it in luxury territory. Small desk, big upgrade: This sit‑stand desk blends space‑saving design with effortless electric height adjustment — perfect for tight spaces. We tried it, and loved its customizable finishes, sleek design, and smart features. More of this week's top reads: The hidden dilemma of Ozempic: eating disorder recovery. Drew Brees says he's a "very common-sense dieter." Here are five simple wellness rules he lives by. Seven things you should never do when traveling by train, according to an etiquette coach. I've lived in the Hamptons for most of my life. Here are five mistakes I see visitors make every summer. The Coldplay "kiss cam" situation underlines a lesson I learned as a 15-year-old cheerleader. I went to a medical clinic in Portugal — thousands of miles from my NYC home. I saved $500 and found an answer for my back pain. I was born and raised in Italy. There are seven things I wish tourists would stop doing when they come here. The millennial case against having baby number three.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store